Carmichael Hill & Associates, Inc. Astrazeneca PLC Transaction History

Carmichael Hill & Associates, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $5,421 - $7,044	-100 Reduced 81.3%	23 $1,000
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $1,277 - $1,398	23 Added 23.0%	123 $7,000
Q1 2021 Apr 28, 2021	SELL	$47.16 - $54.44 $2,358 - $2,722	-50 Reduced 33.33%	100 $5,000
Q2 2020 Aug 05, 2020	BUY	$43.1 - $55.31 $2,155 - $2,765	50 Added 50.0%	150 $8,000
Q4 2019 Jan 30, 2020	BUY	$42.46 - $50.46 $4,246 - $5,046	100 New	100 $5,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.